[{"Assets_0_Q1_USD":1541794000.0,"CommonStockSharesOutstanding_0_Q1_shares":301519885.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":161593000.0,"NetIncomeLoss_1_Q1_USD":75775000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":300542000.0,"EarningsPerShareBasic_1_Q1_USD":0.25,"Ticker":"EXEL","CIK":"939767","name":"EXELIXIS, INC.","OfficialName":"Exelixis Inc. Common Stock","form":"10-Q","period":"20190331","fy":"2019.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"7287350058.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Commercial Physical & Biological Resarch","Market":"NASDAQ","SP500":"nan","filed":"20190501"}]